Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

Marc A. Riedl; Robyn J. Levy; Daniel Suez; Richard F. Lockey; James W. Baker; Anurag Relan; Bruce L. Zuraw

doi:10.1016/j.anai.2013.02.007

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2013.02.007 ◽

2013 ◽

Vol 110 (4) ◽

pp. 295-299 ◽

Cited By ~ 31

Author(s):

Marc A. Riedl ◽

Robyn J. Levy ◽

Daniel Suez ◽

Richard F. Lockey ◽

James W. Baker ◽

...

Keyword(s):

North American ◽

Hereditary Angioedema ◽

Efficacy And Safety ◽

C1 Inhibitor ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01800-3 ◽

2021 ◽

Vol 77 (18) ◽

pp. 441

Author(s):

Eric Bruckert ◽

Sonia Caprio ◽

Albert Wiegman ◽

Min-Ji Charng ◽

Cézar A. Zárate-Morales ◽

...

Keyword(s):

Children And Adolescents ◽

Familial Hypercholesterolemia ◽

Efficacy And Safety ◽

Homozygous Familial Hypercholesterolemia ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study

Download Full-text

Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study

Annals of Dermatology ◽

10.5021/ad.2015.27.4.371 ◽

2015 ◽

Vol 27 (4) ◽

pp. 371 ◽

Cited By ~ 9

Author(s):

Jung-Min Park ◽

Hyun-Ho Cho ◽

Won-Jeong Kim ◽

Je-Ho Mun ◽

Margaret Song ◽

...

Keyword(s):

Betamethasone Dipropionate ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Calcipotriol Betamethasone

Download Full-text

Efficacy and Safety of Thirst-Quenching Lozenges for Xerostomia in Patients Undergoing Hemodialysis: A Prospective, Single-Arm, Open-Label Study

Journal of Clinical Nephrology and Renal Care ◽

10.23937/2572-3286.1510056 ◽

2020 ◽

Vol 6 (2) ◽

Author(s):

Sahay Manisha ◽

Almeida Alan ◽

Naqvi Syed Mujtaba Hussain ◽

Venugopal Hariharan ◽

Kale Ravindra Machhindra ◽

...

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Gastroenterology ◽

10.1053/j.gastro.2015.07.001 ◽

2015 ◽

Vol 149 (4) ◽

pp. 971-980.e1 ◽

Cited By ~ 59

Author(s):

Eric Lawitz ◽

Mihály Makara ◽

Ulus Salih Akarca ◽

Paul J. Thuluvath ◽

Liliana Lucia Preotescu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Efficacy And Safety ◽

Hepatitis C Virus Infection ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Chronic Hepatitis C Virus

Download Full-text

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s79347 ◽

2015 ◽

pp. 1349 ◽

Cited By ~ 3

Author(s):

Ernie Anand ◽

Lovisa Berggren ◽

Claudia Deix ◽

Ágoston Tóth ◽

David McDonnell

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Post Hoc Analysis ◽

Long Acting ◽

Post Hoc

Download Full-text

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.14294 ◽

2018 ◽

Vol 45 (5) ◽

pp. 529-539 ◽

Cited By ~ 26

Author(s):

Shigetoshi Sano ◽

Hiroshi Kubo ◽

Hitomi Morishima ◽

Ryosuke Goto ◽

Richuan Zheng ◽

...

Keyword(s):

Monoclonal Antibody ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Generalized Pustular Psoriasis ◽

Erythrodermic Psoriasis ◽

Interleukin 23

Download Full-text

Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study

European Urology ◽

10.1159/000020056 ◽

1999 ◽

Vol 36 (6) ◽

pp. 609-620 ◽

Cited By ~ 52

Author(s):

C.C. Schulman ◽

J. Cortvriend ◽

U. Jonas ◽

T.M.T.W. Lock ◽

S. Vaage ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Efficacy And Safety ◽

Benign Prostatic Obstruction ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)

BMC Endocrine Disorders ◽

10.1186/s12902-020-0524-7 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Zhenmei An ◽

◽

Ting Lei ◽

Lian Duan ◽

Pei Hu ◽

...

Keyword(s):

Chinese Patients ◽

Prolonged Release ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Active Acromegaly ◽

Lanreotide Autogel

Download Full-text

Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial

Allergy Asthma & Clinical Immunology ◽

10.1186/s13223-020-0409-3 ◽

2020 ◽

Vol 16 (1) ◽

Author(s):

Donald S. Levy ◽

Henriette Farkas ◽

Marc A. Riedl ◽

Florence Ida Hsu ◽

Joel P. Brooks ◽

...

Keyword(s):

Subgroup Analysis ◽

Hereditary Angioedema ◽

Efficacy And Safety ◽

C1 Inhibitor ◽

Open Label ◽

Phase 3 ◽

Term Efficacy ◽

Open Label Extension

Download Full-text

1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel cell carcinoma progressing on anti-PD-(L)1 antibody therapy: The MERKLIN 2 study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1276 ◽

2020 ◽

Vol 31 ◽

pp. S767-S768

Author(s):

A.C.J. van Akkooi ◽

P.A. Ascierto ◽

J.C. Becker ◽

P. Nathan ◽

P. Nghiem ◽

...

Keyword(s):

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Phase Ii ◽

Antibody Therapy ◽

Merkel Cell ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text